Clinical trial Recruiting at 1 site Observational Ages 18 and up

Long-term safety of UAS-assisted vs sheathless RIRS in adults with kidney stones

Official title: Long-Term Safety Outcomes of Ureteral Access Sheath-Assisted Versus Sheathless Retrograde Intrarenal Surgery for Renal Stones ≤20 mm in Non-Prestented Patients: A Retrospective Comparative Cohort Study With Active Follow-up

Run by Al-Azhar University · NCT07767773 · Data updated 2026-11-12

This study tests whether using a ureteral access sheath during the initial RIRS affects long-term safety and outcomes in adults with kidney stones ≤20 mm.

More Urolithiasis trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1200 (estimated)
SponsorAl-Azhar University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedAugust 16, 2026
Main results expectedDecember 1, 2027
Study endsDecember 25, 2027
Registry record updatedAugust 18, 2026
Trial IDNCT07767773 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) who had a primary RIRS for renal stones ≤20 mm at Al-Azhar University Hospitals between 2020 and 2025 and with documented UAS use status.

Probably not a fit

Patients with incomplete records, prior ipsilateral ureteral procedures, complex congenital anomalies, or stone burden >20 mm may not benefit from the findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a retrospective observational cohort study at Al-Azhar University Hospitals from 2020 to 2025, comparing patients who had a ureteral access sheath (UAS) used during their first RIRS to those who did not. Eligible adults with primary RIRS for renal stones ≤20 mm will be identified and invited for follow-up of at least 12 months. The main outcome is a composite of delayed ureteral stricture or new/progressive hydronephrosis on the operated side. Secondary outcomes include intraoperative ureteral injury, postoperative complications, stone-free rate, renal function, emergency visits, readmissions, and need for additional intervention. Analyses will use propensity scores and adjusted regression to minimize confounding from nonrandom treatment assignment.

Why it matters

Potential benefit: If successful, the study could clarify long-term safety differences between UAS-assisted and sheathless RIRS, guiding technique choices to reduce late complications.

How similar studies have gone: Previous studies in this area have shown mixed results; this retrospective approach adds long-term follow-up and confounding control to assess safety.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years at time of index RIRS.
* Primary RIRS performed at Al-Azhar University Hospitals between Jan 1, 2020 and Dec 31, 2025.
* Renal stone(s) with maximum diameter ≤20 mm on preoperative imaging.
* No ipsilateral ureteral stent or nephrostomy before index RIRS.
* Documented operative record specifying whether a UAS was used.
* At least 12 months elapsed since index RIRS.
* Available contact information allowing invitation for active follow-up.

Exclusion Criteria:

* Primary ureteral stone treated during the same procedure.
* Staghorn or \>20 mm stone burden.
* Prior ipsilateral ureteral stricture or reconstructive surgery.
* Congenital renal/ureteral anomalies affecting outcome (e.g., horseshoe kidney, duplicated system).
* Incomplete operative or preoperative imaging records that preclude determination of eligibility or exposure (UAS use).
* Additional ipsilateral ureteral procedure during follow-up that independently causes ureteral narrowing.
* Refusal to participate in active follow-up or failure to attend after repeated attempts.

Where it's running

  • Department of Urology, Al-Hussein and Sayed Galal University Hospitals, Al-Azhar University
    Cairo, Egypt
    Recruiting

Study contacts

  • Principal investigator: Abul-fotouh Ahmed — Department of Urology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
  • Study coordinator: Abul-fotouh Ahmed
  • Email: abulfotouhahmed@yahoo.com
  • Phone: +201001066756

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.